Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2021 May 27.
Published in final edited form as: Cancer Discov. 2021 May;11(5):1306. doi: 10.1158/2159-8290.CD-21-0224

Retraction: Increased Levels of COX-2 and Prostaglandin E2 Contribute to Elevated Aromatase Expression in Inflamed Breast Tissue of Obese Women

Kotha Subbaramaiah, Patrick G Morris, Xi Kathy Zhou, Monica Morrow, Baoheng Du, Dilip Giri, Levy Kopelovich, Clifford A Hudis, Andrew J Dannenberg
PMCID: PMC8158642  NIHMSID: NIHMS1705437  PMID: 33947719

This article (1) has been retracted at the request of the authors based upon evidence of data falsification or fabrication in Figs. 2B, 4C, and 5H. An Editor’s Note had previously been issued (2). A copy of this Retraction Notice was sent to the last known e-mail addresses for the 9 authors. Eight authors (Kotha Subbaramaiah, Patrick G. Morris, Xi Kathy Zhou, Monica Morrow, Dilip Giri, Levy Kopelovich, Clifford A. Hudis, and Andrew J. Dannenberg) agreed to the retraction; one author (Baoheng Du) did not respond. The authors apologize to the scientific community and deeply regret any inconveniences or challenges resulting from the publication and subsequent retraction of this article.

REFERENCES

  • 1.Subbaramaiah K, Morris PG, Zhou XK, Morrow M, Du B, Giri D, et al. Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women. Cancer Discov 2012;2:356–65. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 2.Editor’s Note: Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women. Cancer Discov 2019;9:1142. [DOI] [PubMed] [Google Scholar]

RESOURCES